Inpatient admissions for drug-induced liver injury: Results from a single center

Digestive Diseases and Sciences

Volumn 53, Issue 7, 2008, Pages 1977-1982

  Carey, Elizabeth J ^a   Vargas, Hugo E ^a   Douglas, David D ^a   Balan, Vijayan ^a   Byrne, Thomas J ^a   Harrison, M Edwyn ^a   Rakela, Jorge ^a  

^a MAYO CLINIC   (United States)

Author keywords

Drug induced liver injury; Fulminant hepatic failure; Hepatotoxicity

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANABOLIC AGENT; ATORVASTATIN; AZATHIOPRINE; AZITHROMYCIN; CARBAMAZEPINE; CEFTRIAXONE; CIPROFLOXACIN; DAPSONE; LEVOFLOXACIN; PARACETAMOL; QUETIAPINE; RETINOL; SIMVASTATIN; SULINDAC; TROVAFLOXACIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER CELL DAMAGE; LIVER INJURY; LIVER TOXICITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

ACETAMINOPHEN; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; FEMALE; HEPATITIS, TOXIC; HUMANS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OVERDOSE; PATIENT ADMISSION; TREATMENT OUTCOME;

EID: 44449099050     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0250-x     Document Type: Article

References (21)

1. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, Lenoir C, Lemoine A, Hillon P (2002) Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 36:451-455
2. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SHB, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM, the U.S. Acute Liver Failure Study Group (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137:947-954
3. Bakke OM, Manocchia M, De Abajo F, Kaitin KI, Lasagna L (1995) Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective. Clin Pharmacol Ther 58:108-117
4. Benichou C (1990) Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 11:272-276
5. Danan G, Benichou C (1999) Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46:1323-1330
6. Bjornsson E, Jerlstad P, Bergqvist A, Olsson R (2005) Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol 40:1095-1101
7. Drug-Induced Liver Injury Network. Available at: http://dilin.dcri.duke. edu/. Accessibility verified November 21, 2006
8. Ibanez L, Perez E, Vidal X, Laporte JR, the Grup d'Estudi Multicentric d'Hepatotoxicitat Aguda de Barcelona (GEMHAB) (2002) Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. J Hepatol 37:592-600
9. Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E, Garcia-Munoz B, Gonzalez-Grande R, Pizarro A, Duran JA, Jimenez M, Rodrigo L, Romero-Gomez M, Navarro JM, Planas R, Costa J, Borras A, Soler A, Salmeron J, Martin-Vivaldi R (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512-521
10. Wei G, Bergqvist A, Broome U (2004) Acute liver failure in Sweden: etiology and prognosis [abstract 48]. Scand J Gastroenterol 240(39 Suppl):36
11. O'Grady JG, Alexander GJM, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439-445
12. Friis H, Andreasen PB (1992) Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish committee on adverse drug reactions between 1978 and 1987. J Intern Med 232:133-138
13. Galan MV, Potts JA, Silverman AL, Gordon SC (2005) The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center. J Clin Gastroenterol 39:64-67
14. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P (2004) Liver transplantation for acute liver failure from drug-induced liver injury in the United States. Liver Transpl 10:1018-1023
15. Smith IDM, Simpson KJ, Garden OJ, Wigmore SJ (2005) Non-paracetamol drug-induced fulminant hepatic failure among adults in Scotland. Eur J Gastroenterol Hepatol 17:161-167
16. Aithal PG, Day CP (1999) The natural history of histologically proved drug induced liver disease. Gut 44:731-735
17. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990-1997. JAMA 280:1569-1575
18. Larrey D (1997) Hepatotoxicity of herbal remedies. J Hepatol 26(Suppl 1):47-51
19. Saper RB, Kales SN, Paquin J, Burns MJ, Eisenberg DM, Davis RB, Phillips RS (2004) Heavy metal content of ayurvedic herbal medicine products. JAMA 292:2868-2873
20. Zimmerman HJ (1999) Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver, 2nd edn. Philadelphia: Lippincott Williams & Wilkins
21. Hawton K, Simkin K, Deeks K, Cooper J, Johnston A, Waters K, Arundel M, Bernal W, Hudson M, Suri D, Simpson K (2004) UK legislation on analgesic packs: before and after study on long term effect of poisonings. Br Med J 329:1076-1081